FRONTEO and Tokyo Tech Establish Industry-Academia Collaborative Research Center for AI Drug Discovery
NQ Score
91/100
N1 Content Completeness
95
AI Summary (NQ-processed)
FRONTEO Inc. and National University Corporation Tokyo Institute of Science and Technology (Tokyo Tech) established the "FRONTEO AI Drug Discovery Ecosystem Collaborative Research Center" within Tokyo Tech's Yokohama Campus on April 1, 2026. This center aims to integrate FRONTEO's equation-driven AI "KIBIT" with Tokyo Tech's advanced technologies like the PLOM-CON analysis method and reseal cell technology to enable seamless execution from hypothesis generation to experimental verification in AI drug discovery. The goal is to promote the social implementation of cutting-edge technologies in AI drug discovery and foster drug discovery innovation originating from Japan. A signing ceremony was held today, April 27.